Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by FirstLaw PCSehwan Choi of FirstLaw provides an overview of Qualcomm’s IP policy as well as related disputes concerning SEPs and FRAND commitments in Korea -
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Nathan Wood of Satyapon & Partners look at the growing business of medical mask counterfeiting as a result of COVID-19 and explore the ways in which trademark owners can protect themselves, preferably through registration, or failing that, through recourse to criminal law
-
Sponsored by Hechanova GroupEditha Hechanova of Hechanova & Co examines the option of licensing for businesses interested in the Philippine market, looking at the rules relating to essential provisions, terms and conditions and non-compete clauses
-
Sponsored by Beijing East IPYongyu Zhang of Beijing East IP examines trends and developments in the fields of patents and trademarks, looking at application patterns, disputes and changes in the law
-
Sponsored by SS RanaVikrant Rana of SS Rana analyses Japan and India’s close relationship in the field of IP, examining the Patent Prosecution Highway programme, the countries’ digital partnership and the establishment of a start-up hub
-
Sponsored by Bird & BirdRichard Vary, Clemens Heusch and Matthias Schneider reveal their views on component-level versus end-point licensing and Unwired Planet
